Keynote speaker
Paul Huntly, Managing Director & CEO, Riskren PTE Ltd, Singapore
Pres
enting
Workshop 2: Confident in your biosafety / biosecurity controls – really? (Monday 29 October, 1.30pm - 5.00pm)
Keynote Presentation: Biorisk management and assurance – where are we and where are we going? (Wednesday 31 October 2018, 10.45am - 11.30am)
Dr Paul Huntly specialises in assessment and management of biological risk in laboratories, vaccine manufacture and the healthcare sector. Paul has provided consultancy advice and assessment support in this area for over 15 years, working with numerous governmental and private sector organisations. He was the originator of the term and concept biorisk management, and closely involved with the development of a number of key standards in this area, most notably CWA 15793: Laboratory Biorisk Management, together with ‘GAPIII’ relating to poliovirus post-eradication controls. Paul is based in Singapore, but works extensively throughout Asia and the rest of the world.
Invited speaker
Francesca Casu, University of Auckland, New Zealand
Presenting
The journey of the University of Auckland: from compliance to verification (Wednesday 31 October 2018, 11.30am - 12.00pm)
Francesca is the Hazard and Containment Advisor at the University of Auckland. She helps to manage the Containment and Transitional facilities, and provides expert advice regarding the good practice use of ‘risk biologicals’ and chemicals. Francesca is also the University’s Laser Safety Officer.
Before undertaking this role, Francesca worked as and Laboratory Manager and Teaching Technician in the School of Biological Science (University of Auckland), while she also completed her PhD in Microbial Metabolomics and Wine Science.
Her passion for microbiology never leaves her and she enjoys baking with her five years old sourdough!
David Smith, PathWest Laboratory Medicine WA, Australia
Presenting
Biosafety in an era of pathogen discovery: Risk assessing the unknown (Thursday 1 November, 2.10pm - 2.40pm)
Clinical Professor David Smith is a graduate of the University of Western Australia. He is a Clinical Virologist at PathWest Laboratory Medicine, QEII Medical Centre, and a Clinical Professor in the Faculty of Health and Medical Sciences at UWA. He is Director of the National Influenza Centre and is lead for the Arbovirus Surveillance and Research Laboratory. He has a particular interest in public health issues and serves on state, national and international committees and advisory groups. Currently he is part of two national collaborative Centres of Research Excellence related to emerging and exotic infections.